Halofuginone Induces Matrix Metalloproteinases in Rat Hepatic Stellate Cells via Activation of p38 and NFκB*

The semisynthetic plant alkaloid halofuginone (HAL) was reported to prevent and partly reverse experimental liver fibrosis. However, its mechanisms of action are poorly understood. We therefore aimed to determine the antifibrotic potential of HAL and to characterize involved signal transduction pathways in hepatic stellate cells (HSCs). Results were compared with its in vivo effects in a rat model of reversal of established liver fibrosis induced by thioacetamide. In vitro HAL inhibited HSC proliferation and migration dose dependently at submicromolar concentrations. HAL (200 nm) up-regulated matrix metalloproteinase (MMP)-3 and MMP-13 expression between 10- and 50-fold, resulting in a 2- to 3-fold increase of interstitial collagenase activity. Procollagen α1(I) and MMP-2 transcript levels were suppressed 2- to 3-fold, whereas expression of other profibrogenic mRNAs remained unaffected. p38 mitogen-activated protein kinase (p38 MAPK) and nuclear factor κB(NFκB) pathways were activated by HAL, and specific inhibitors of p38 MAPK and NFκB dose dependently inhibited MMP-13 induction. Treatment with HAL did not affect HSC viability, and observed effects were reversible after its removal. In vivo HAL up-regulated MMP-3 and -13 mRNA expression 1.5- and 2-fold, respectively, in cirrhotic rats, whereas tissue inhibitor of metalloproteinase-1 was suppressed by 50%. In conclusion, submicromolar concentrations of HAL inhibit HSC proliferation and migration and up-regulate their expression of fibrolytic MMP-3 and -13 via activation of p38 MAPK and NFκB. The remarkable induction of MMP-3 and -13 makes HAL a promising agent for antifibrotic combination therapies.

[1]  V. Carloni,et al.  Signal transduction in hepatic stellate cells. , 2008, Liver.

[2]  Yury Popov,et al.  Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. , 2005, Journal of hepatology.

[3]  D. Schuppan,et al.  Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat , 2005, Hepatology.

[4]  D. Schuppan,et al.  Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. , 2005, Gastroenterology.

[5]  Chien-Hung Chen,et al.  Differential Role of p38 in IL-1α Induction of MMP-9 and MMP-13 in an Established Liver Myofibroblast Cell Line , 2003, Journal of Biomedical Science.

[6]  Katsunori Yoshida,et al.  p38 MAPK mediates fibrogenic signal through smad3 phosphorylation in rat myofibroblasts , 2003, Hepatology.

[7]  A. Nagler,et al.  Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  D. Schuppan,et al.  Reciprocal modulation of matrix metalloproteinase-13 and type I collagen genes in rat hepatic stellate cells. , 2003, The American journal of pathology.

[9]  J. Iredale,et al.  Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[10]  David A. Brenner,et al.  The Role of Focal Adhesion Kinase-Phosphatidylinositol 3-Kinase-Akt Signaling in Hepatic Stellate Cell Proliferation and Type I Collagen Expression* , 2003, The Journal of Biological Chemistry.

[11]  D. Brenner,et al.  Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. , 2003, Gastroenterology.

[12]  T. McGaha,et al.  Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism. , 2002, Arthritis and rheumatism.

[13]  J. Jaffrezou,et al.  p38 MAPK mediates the regulation of α1(I) procollagen mRNA levels by TNF‐α and TGF‐β in a cell line of rat hepatic stellate cells 1 , 2002 .

[14]  Jiahuai Han,et al.  Activation of p38α MAPK Enhances Collagenase-1 (Matrix Metalloproteinase (MMP)-1) and Stromelysin-1 (MMP-3) Expression by mRNA Stabilization* , 2002, The Journal of Biological Chemistry.

[15]  J. Armendáriz-Borunda,et al.  Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. , 2002, Gastroenterology.

[16]  S. Friedman,et al.  Activation of hepatic stellate cells--a key issue in liver fibrosis. , 2002, Frontiers in bioscience : a journal and virtual library.

[17]  D. Brenner,et al.  TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells , 2001, Hepatology.

[18]  S. Friedman,et al.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. , 2001, The Journal of clinical investigation.

[19]  M. Arthur,et al.  Extracellular Matrix Degradation and the Role of Hepatic Stellate Cells , 2001, Seminars in liver disease.

[20]  W. Parks,et al.  p38 mitogen-activated kinase is a bidirectional regulator of human fibroblast collagenase-1 induction by three-dimensional collagen lattices. , 2001, The Biochemical journal.

[21]  T. Roskams,et al.  Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. , 2001, Journal of hepatology.

[22]  D. Valla,et al.  Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. , 2001, The New England journal of medicine.

[23]  A. Nagler,et al.  Halofuginone to prevent and treat thioacetamide‐induced liver fibrosis in rats , 2001, Hepatology.

[24]  J. Iredale,et al.  Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. , 2000, Histology and histopathology.

[25]  K. Kameyama,et al.  Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. , 2000, Journal of hepatology.

[26]  D. Schuppan,et al.  An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. , 2000, Gastroenterology.

[27]  G. Ramadori,et al.  Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat , 2000, Histochemistry and Cell Biology.

[28]  H. Reeves,et al.  Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. , 2000, Journal of hepatology.

[29]  C. Garret,et al.  A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia. , 1999, Gastroenterology.

[30]  R. Timpl,et al.  Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair , 1999, Histochemistry and Cell Biology.

[31]  D. Brenner,et al.  NF-kappaB inhibits expression of the alpha1(I) collagen gene. , 1999, DNA and cell biology.

[32]  J. Iredale,et al.  Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation , 1999, Hepatology.

[33]  M. Arthur,et al.  Persistent activation of nuclear factor‐κB in cultured rat hepatic stellate cells involves the induction of potentially novel rel‐like factors and prolonged changes in the expression of IκB family proteins , 1999, Hepatology.

[34]  A. Hochberg,et al.  Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  D. Schuppan,et al.  A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture , 1999, Hepatology.

[36]  C. López-Otín,et al.  Induction of Collagenase-3 (MMP-13) Expression in Human Skin Fibroblasts by Three-dimensional Collagen Is Mediated by p38 Mitogen-activated Protein Kinase* , 1999, The Journal of Biological Chemistry.

[37]  A. Kossakowska,et al.  Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. , 1998, The American journal of pathology.

[38]  J. Westermarck,et al.  Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[39]  D. Brenner,et al.  Inhibition of NFκB in activated rat hepatic stellate cells by proteasome inhibitors and an IκB super‐repressor , 1998 .

[40]  M. Pines,et al.  Halofuginone: a novel antifibrotic therapy. , 1998, General pharmacology.

[41]  M. Kaplan,et al.  Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis , 1997, Annals of Internal Medicine.

[42]  T. Takahara,et al.  Dual expression of matrix metalloproteinase‐2 and membrane‐type 1‐matrix metalloproteinase in fibrotic human livers , 1997, Hepatology.

[43]  P. Heinrich,et al.  TIMP expression in toxic and cholestatic liver injury in rat. , 1997, Journal of hepatology.

[44]  O. Halevy,et al.  Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone. , 1996, Biochemical pharmacology.

[45]  D. Schuppan,et al.  Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. , 1994, The American journal of pathology.

[46]  E. Hertzberg,et al.  Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[47]  O. Halevy,et al.  Halofuginone: an inhibitor of collagen type I synthesis. , 1993, Biochimica et biophysica acta.

[48]  M. Pines,et al.  Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone. , 1991, Poultry science.

[49]  S. Friedman,et al.  Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. , 1989, The Journal of biological chemistry.

[50]  E. Schiff,et al.  Histological outcome during long-term lamivudine therapy. , 2003, Gastroenterology.

[51]  M. Pines,et al.  Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone. , 1997, Arteriosclerosis, thrombosis, and vascular biology.